Chestnut Ridge, NY, United States of America

Andrew S Katocs, Jr


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Andrew S. Katocs, Jr.

Introduction

Andrew S. Katocs, Jr. is an innovative inventor based in Chestnut Ridge, New York. He has made significant contributions to the field of medicine, particularly in the treatment of coronary artery disease. His pioneering work has garnered attention within the medical community and beyond.

Latest Patents

Andrew S. Katocs, Jr. holds a notable patent titled "Use of Retinoids for the Treatment of Coronary Artery Disease." This invention focuses on a method to increase plasma high-density lipoprotein levels, which is vital for the treatment and prevention of coronary artery disease. The method involves administering a therapeutic amount of a retinoid as described in the generalized formula.

Career Highlights

Katocs is associated with the American Cyanamid Company, where he contributes his expertise in pharmaceutical innovation. His work has positioned him as a valuable asset in the field of medical treatments and drug development.

Collaborations

During his career, Andrew has collaborated with esteemed colleagues such as Elwood Eugene Largis and Sotirios K. Karathanasis. These partnerships have enriched his research and led to advancements in their collective work.

Conclusion

Andrew S. Katocs, Jr. exemplifies the spirit of innovation in the medical field. His contributions, particularly in the treatment of coronary artery disease, hold promise for improving healthcare outcomes. As inventions like his continue to emerge, the potential for advancements in medical treatments remains bright.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…